SGLT-2 inhibitors, which help eliminate excess glucose through urine, are another emerging approach
Hypoglycemic Awareness: Concurrent administration with insulin or sulfonylurea-based therapies may increase the physiological risk of glucose depletion markers
Firstly, using the CPRD allowed for the ability to adjust for important potential confounders, including cardiovascular risk factors, microvascular and macrovascular complications, body mass index, and laboratory measures, which are often unavailable in other datasets
Newsome, PhD, FRCPE, director of Roger Williams Institute of Liver Studies at Kings College London, told attendees at The Liver Meeting
Monitor for Side Effects Be aware of potential side effects and report any new or worsening symptoms to your healthcare team